Prochlorperazine Edisylate Injection
Product Images NDC 55154-4183

3 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 55154-4183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 01)

Structure (Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 01)
A data table listing NDC 55154-4183-5 for Prochlorperazine Edisylate injection, showing it is supplied as 2 mL (10 mg) vials in bags of 5 vials, with the labeler Cardinal Health 107, LLC.*
FDA Label Image

Logo (Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 03)

FDA Label Image

10mg/2ml Bag Label (Aa344274 7751 40fa B8d9 3ad2c340d793 00)

10mg/2ml Bag Label (Aa344274 7751 40fa B8d9 3ad2c340d793 00)
Prochlorperazine Edisylate Injection, USP 10 mg/2 mL (5 mg/mL) in multiple-dose vials packaged as 5 vials of 2 mL each. Label includes dosing strength, route of administration (intramuscular and intravenous), storage instructions, warnings, manufacturing, and distributor information. Labeler is Cardinal Health 107, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.